Asuragen, Inc., a leading molecular diagnostics company headquartered in the United States, has been at the forefront of innovative solutions since its founding in 2006. With a strong focus on oncology and genetic testing, Asuragen develops cutting-edge products that empower healthcare professionals to make informed decisions.
The company’s core offerings include a range of proprietary assays and diagnostic tools that are distinguished by their accuracy and reliability. Asuragen's commitment to advancing precision medicine has positioned it as a key player in the molecular diagnostics industry, with notable achievements in the development of tests for cancer and genetic disorders.
With operations extending across major regions in the US and a growing international presence, Asuragen continues to drive advancements in molecular testing, enhancing patient care and outcomes worldwide.
+2 vs industry average
Asuragen, Inc.’s score of 29 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Asuragen, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Asuragen, Inc. yet.
Asuragen, Inc.'s reported carbon emissions
Asuragen, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. However, the company is part of a corporate family that includes Bio-Techne Corporation, from which it inherits climate commitments and performance data.
Asuragen's climate initiatives and reduction targets are aligned with those of Bio-Techne Corporation, which operates at a cascade level of 1. This means that any significant climate commitments or targets set by Bio-Techne may influence Asuragen's sustainability strategies. Unfortunately, specific reduction targets or achievements have not been disclosed for Asuragen, nor are there any documented climate pledges.
In summary, while Asuragen, Inc. does not provide its own emissions data or specific climate commitments, it is linked to Bio-Techne Corporation's sustainability efforts, which may guide its environmental strategies moving forward.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Asuragen, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Asuragen, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Bio-Techne Corporation
Carbon Disclosure Project
Inherited from Bio-Techne Corporation
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Asuragen, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project